Biotechnology

As biotechnology industry expands, so does the need for strategic marketing approaches to reach investors, regulatory bodies, healthcare providers, and consumers…read more

Biotechnology

The Future of Marketing in the Biotechnology Industry: The Role of Press Release Distribution

The biotechnology industry is experiencing rapid advancements in gene editing, personalized medicine, synthetic biology, and biopharmaceuticals. As the industry expands,…

Read More

Stay Aware: Remote Employees Impact Venue Options In Patent Litigation

For many patent cases, the United States District Court hearing your patent dispute can have a big impact on case…

Biotechnology

Eye Therapies v. Slayback Pharma – Fed. Cir. Enhances the Scope of “Consisting Essentially” |

In Eye Therapeutics, LLC, v. Slayback Pharma, LLC., Appeal no. 2023-2173, (Fed. Cir., June 30, 2025), a panel of Judges…

Biotechnology

Federal Circuit Vacates $300 Million Verdict Against Apple, Orders Third Trial in LTE Patent Dispute

In a pivotal ruling for patent damages and standard-essential patent (SEP) litigation, the Federal Circuit vacated a $300 million award…

Biotechnology

Their Grip on s. 102 Inquiries |

So that I don’t have to explain the claims and the arguments presented by the parties, please read my posts…

Biotechnology

AI, Algorithms and Abstract Ideas: Federal Circuit Reinforces Limits in Recentive v. Fox

In April, the Federal Circuit issued a significant patent law ruling involving artificial intelligence. In Recentive Analytics, Inc. v. Fox…

Biotechnology

Sigray, Inc. v. Carl Zeis X-Ray Microscopy, Inc.—When does “No” Projection Magnification Mean “No”? |

In Sigray, Inc, v. Carl Zeis X-Ray , appeal 2023-2211 (Fed. Cir., May 23, 2025), the panel reviewed the Board’s…

Biotechnology
Show More